Back
Bicycle Therapeutics PLC Stock Predictions
Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
27
BCYC
Bicycle Therapeutics PLC
Last Price:
$8.06
Seasonality Move:
13.85%
7 Day Trial
ALL ACCESS PASS
$
7
Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Bicycle Therapeutics PLC Stock Forecast
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 5.7% based on the past 5 years of stock performance.
-
Bicycle Therapeutics PLC has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Bicycle Therapeutics PLC Stock Undervalued?The current Bicycle Therapeutics PLC [BCYC] share price is $8.05. The Score for BCYC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
BCYC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Bicycle Therapeutics PLC Stock Go Up Next Year?
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 5.7% based on the past 5 years of stock performance.
Bicycle Therapeutics PLC Stock Rating
Sell
27
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC overpriced?
-
Bicycle Therapeutics PLC has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Bicycle Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bicycletherapeutics.com
52-Week Data
52-Week High:
28.67
52-Week Low:
6.10
Prediction Charts
Market Cap:
557.5M
Price in USD:
8.05
Volume:
132K
Beta:
0.94
Technical Analysis
SMA50:
8.25
SMA100:
10.45
SMA200:
16.46
52-Wk Change:
-65.72%
Stock Predictions
-
Is Bicycle Therapeutics PLC stock public?Yes, Bicycle Therapeutics PLC is a publicly traded company.
-
What is the Bicycle Therapeutics PLC stock quote today?The Bicycle Therapeutics PLC stock price is 8.05 USD today.
-
How to buy Bicycle Therapeutics PLC stock online?You can buy Bicycle Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-6 | 9.03 | 7.40 | 9.08 | 7.39 |
| May-7 | 7.79 | 7.78 | 8.04 | 7.39 |
| May-8 | 7.77 | 8.18 | 8.27 | 7.51 |
| May-9 | 8.37 | 8.34 | 8.60 | 8.13 |
| May-12 | 8.68 | 8.60 | 9.00 | 8.38 |
| May-13 | 8.63 | 8.11 | 8.80 | 8.09 |
| May-14 | 8.08 | 8.01 | 8.17 | 7.88 |
| May-15 | 8.03 | 8.12 | 8.26 | 7.83 |
| May-16 | 8.10 | 8.10 | 8.39 | 8.03 |
| May-19 | 8.00 | 8.63 | 8.66 | 8.00 |
| May-20 | 8.70 | 8.51 | 8.73 | 8.47 |
| May-21 | 8.39 | 8.05 | 8.64 | 8.00 |
| May-22 | 7.99 | 8.10 | 8.17 | 7.89 |
| May-23 | 7.96 | 8.05 | 8.10 | 7.91 |
Bicycle Therapeutics PLC Earnings
Bicycle Therapeutics PLC Earnings Report: Per Share Bicycle Therapeutics PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.
Bicycle Therapeutics PLC Forecast Revenue Growth
Bicycle Therapeutics PLC Stock Analysis: Historical quarterly revenues per share for Bicycle Therapeutics PLC and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.52 per share.
* Bicycle Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.